Cardiac Biotech Solutions, Inc. (OTCID: CBSC) (“CBSC” or the “Company”), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products, today provided an update on ...
According to Cardiac Event Monitor Markets: Market Shares, Strategies, and Forecasts, 2017 to 2023 report, growth is based on implementation of devices that measure cardiac function over a period of a ...
ESCONDIDO, CA / ACCESSWIRE / September 6, 2022 / CB Scientific. Inc.(OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring ...
LAS VEGAS, NV / ACCESS Newswire / February 25, 2025 / CB Scientific, Inc. (CBSC) (OTC PINK:CBSC) ("CBSC" or the "Company"), a designer, manufacturer and distributor of non-invasive ambulatory cardiac ...
ESCONDIDO, CA / ACCESSWIRE / May 24, 2022 / CB Scientific. Inc. (OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products ...
A smartphone app that tracks palpitations in heart patients provides comparable performance to the 14-day event monitors that are the current standard of care, according to a UB study presented last ...
The "Cardiac Monitoring Market - Focused Insights 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Cardiac Monitoring Market was valued at USD 8.24 billion in 2024, and is ...
PaceMate delivers a patient management solution that addresses the full cardiac device care continuum. SARASOTA, Fla., May 19, 2023 /PRNewswire/ -- PaceMate ® announced today its collaboration with ...
Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. Latest data showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results